VAC · Marriott Vacations Worldwide Corporation

Current Thesis

Marriott Vacations Worldwide’s earnings-led re-rating has failed its published price test; the next quarterly results must establish whether the operating recovery survives the broken market structure. The 2026-09-11 adjusted close of $103.59 breached the $106 weekly-close invalidation published on 2026-08-30. That condition has occurred; the original re-rating thesis cannot remain active under a lower threshold.

The distinction is between measured operating improvement and its market interpretation. The company’s 2026-08-06 results raised full-year adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) guidance to $805–830 million. The inference is that the narrative is dead as a continuation of the post-results advance — the 2026-09-11 weekly close broke its published condition, although that price event does not establish that company guidance has failed.

The refresh also contains favorable developments. The company confirmed its quarterly dividend on 2026-09-02, and GuruFocus reported that Truist raised its analyst price target on 2026-09-10. Neither development prevented the subsequent weekly close below $106. Company dividend announcement, Truist action reported by GuruFocus.

Bullish and bearish views on Marriott Vacations Worldwide Corporation

The model's bull view on Marriott Vacations Worldwide Corporation (VAC), in brief: Operating improvement remains documented. The bear view: The published condition has occurred. The 2026-09-11 adjusted close of $103.59 was below the $106 weekly threshold in the 2026-08-30 dossier. The favorable second-quarter report did not preserve that price structure. Growth depended on sales productivity. The 2026-08-06 results… Both cases follow in full.

Bull Case

• Operating improvement remains documented. In its 2026-08-06 second-quarter release, Marriott Vacations reported contract sales of $545 million, up 22% year over year, and raised full-year adjusted EBITDA guidance to $805–830 million from $755–780 million. Those are the operating foundations of the recovery case; a subsequent reduction below the raised range would contradict it.
• Dividend dates are now confirmed. The 2026-09-02 company announcement authorized $0.80 per common share, payable on or around 2026-09-30 to holders of record on 2026-09-16. This replaces the previous unconfirmed September estimate with an actual declaration. Company announcement.
• An analyst raised the valuation. GuruFocus reported on 2026-09-10 that Truist maintained its positive rating and raised its price target to $134 from $97. This is Truist’s valuation judgment, not evidence that the market has repaired the breached structure. Reported analyst action.

Bear Case

• The published condition has occurred. The 2026-09-11 adjusted close of $103.59 was below the $106 weekly threshold in the 2026-08-30 dossier. The favorable second-quarter report did not preserve that price structure.
• Growth depended on sales productivity. The 2026-08-06 results reported volume per guest (VPG) growth of 23% while reported tours declined 1%. The inference is that the recovery remains sensitive to productivity: declining VPG alongside flat or falling tours at the next results would undermine the mechanism behind second-quarter growth.
• Insider distribution is documented. The previously cited Form 4 reported Impactive Capital’s sale of 750,000 shares at $111.49 on 2026-08-19. This establishes a dated third-party transaction; it does not establish continuing sales or explain the September decline by itself.

Setup & Price Structure

The public adjusted-price series records a 2026-09-11 close of $103.59, a three-month price increase of 10.9%, and a price 17.0% below its $124.75 52-week high. Its 14-period relative strength index (RSI) was 38.9. The positive three-month change does not reverse the observed breach of the previously published $106 threshold.

Attention has continued despite that breach. Zacks published momentum-oriented coverage on 2026-09-02 and another recovery article on 2026-09-10. This small sample is insufficient to establish retail crowding, expanding participation or saturation; it establishes only that favorable coverage persisted. September 2 coverage, September 10 coverage.

A current moving-average level, comparable volume history and short-interest series are missing from the evidence available for this refresh. No conclusion about extension above a rising average or a squeeze follows from the supplied RSI alone.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Expected dividend payment. The 2026-09-02 announcement specifies payment on or around this date. Completion would fulfill the declared distribution, without resolving the operating recovery. Company announcement.
• ~2026-11-04, estimated — Third-quarter results. Outside the next 30 days, MarketBeat estimates this date and explicitly says the company has not confirmed it. This replaces the prior November estimate; the results are the relevant test of the $805–830 million full-year adjusted EBITDA guidance announced on 2026-08-06. MarketBeat earnings calendar.

Elapsed catalysts

• 2026-09-16 — Dividend record date. The company’s 2026-09-02 declaration fixes eligibility for the $0.80-per-share distribution. It supplies no new contract-sales or credit-performance measurement. Company announcement. (passed 4d ago)
• 2026-09-16 — Federal Reserve decision. The Federal Open Market Committee (FOMC) calendar confirms the 2026-09-15–16 meeting. This is a macro event relevant to the financing exposure disclosed in the company’s 2026-08-06 results; no directional rate forecast is made. Federal Reserve calendar. (passed 4d ago)

What Would Change Our Mind

The lost post-results structure is already a finding: a weekly close below $106 was the published thesis-break condition, and the 2026-09-11 close of $103.59 satisfied it. The original continuation case is invalidated.

A subsequent weekly close above $106, accompanied by the next results retaining the 2026-08-06 adjusted EBITDA range of $805–830 million, would support a separate recovery assessment. That conditional assessment would fail on another weekly close below $106 or a reduction beneath the guidance range. It would not erase the September invalidation.

Correlation Notes

This remains a single-company recovery assessment. The 2026-08-06 results disclosed approximately $3.1 billion of corporate debt and $2.4 billion of non-recourse debt. Those figures support an inference of exposure to financing conditions and consumer credit, but they do not measure a stock-price correlation with interest rates or travel peers.

No matched return sample is supplied as of 2026-09-11, so neither a correlation coefficient nor a claim of sector leadership is supported. The confirmed 2026-09-16 FOMC event is a shared macro exposure, not evidence that a group advance will restore VAC’s broken structure. Federal Reserve calendar.